03 Mar, 2026.
The IN-ARMOR project had a prominent presence at the recent ‘Information Day on funding opportunities for international collaboration in R&D&I: HEALTH’ organised by SPRI and Innobasque (Basque Innovation Agency) in collaboration with CDTI (Centre for Technological Development and Innovation), the Basque Health Cluster, the Basque Government, the Basque Foundation for Health Innovation and Research (BIOEF) and the Polytechnic University of Catalonia. Ángel del Pozo, representative of the Biokeralty Research Institute, was responsible for presenting the project as a successful model for obtaining European funding and transnational cooperation.
During his speech, del Pozo highlighted how IN-ARMOR, funded by the Horizon Europe programme, addresses one of the ten major public health challenges of our time: Antimicrobial Resistance (AMR). The project proposes a paradigm shift through Host-Directed Therapy (HDT), which seeks to boost the body’s innate immunity rather than directly attacking pathogens with traditional antibiotics.
A model of European cooperation
The presentation highlighted the structure of the IN-ARMOR consortium, which brings together 16 organisations from 10 countries, including elite universities, research centres and industrial partners.
Global impact and innovative solutions
The relevance of this type of project is even more evident following reports from the WHO, which warn that resistance to essential antibiotics continues to increase dramatically worldwide.
Participation in this SPRI forum reinforces IN-ARMOR’s commitment to political dialogue and knowledge transfer to regulators and legislators, a fundamental pillar for facilitating access to these innovative therapies for European citizens.
Driving the future of healthcare: discover how our research is transforming lives via our website and official channels.
